1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016


DelveInsight’s, “ Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer). DelveInsight’s Report also assesses the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope
- The report provides competitivepipeline landscape of Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Table Of Contents

Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)-Pipeline Insights, 2016

Illustrative Table of contents

- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Overview
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Pipeline Therapeutics
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Therapeutics under Development by Companies
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Filed and Phase III Products
- Comparative Analysis
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Phase II Products
- Comparative Analysis
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Phase I and IND Filed Products
- Comparative Analysis
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Discontinued Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Dormant Products
- Companies Involved in Therapeutics Development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), 2016
- Number of Products under Development by Companies
- Comparative Analysis by Filed and Phase III Products, 2016
- Comparative Analysis Phase II Products, 2016
- Comparative Analysis Phase I and IND Filed Products, 2016
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2016
- Drug Candidates Profiles
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Monotherapy Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Combination Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Route of Administration
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Stage and Route of Administration
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Molecule Type
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Stage and Molecule Type
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Therapeutics - Discontinued Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Therapeutics - Dormant Products
- Products under Development by Companies, 2016

List of Figures

- Number of Products under Development for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer), 2016
- Filed and Phase III Products, 2016
- Phase II Products, 2016
- Phase I and IND Filed Products, 2016
- Discovery and Pre-Clinical Stage Products, 2016
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Monotherapy Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Combination Products
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Route of Administration
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Stage and Route of Administration
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Molecule Type
- Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Bladder Cancer: Analytical Tool

Bladder Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

Bladder cancer- Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

Note*: This report requires 5 business days to complete. DelveInsight’s Bladder cancer - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global ...

Bladder cancer - Epidemiology Forecast To 2023

Bladder cancer - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Bladder cancer - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Bladder cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). ...


Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US

  • December 2016
    112 pages
  • Cancer  

  • United States  

    North America  

View report >

Cancer Statistics in the US - Forecast

  • November 2016
    4 pages
  • Cancer  

  • United States  

    New Zealand  

View report >

Cancer Statistics in the US

  • November 2016
    7 pages
  • Cancer  

    Tobacco  

  • United States  

View report >

Related Market Segments :

Bladder Cancer

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.